ARWR stock forecast
Our latest prediction for Arrowhead Pharmaceuticals, Inc.'s stock price was made on the Jan. 6, 2020 when the stock price was at 59.44$.
In the short term (2weeks), ARWR's stock price should underperform the market by -4.26%. During that period the price should oscillate between -8.14% and +7.63%.
In the medium term (3months), ARWR's stock price should underperform the market by -9.04%. During that period the price should oscillate between -27.84% and +20.04%.Get email alerts
About Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops medicines that treat intractable diseases by silencing the genes that cause them. The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA.
At the moment the company generates 169M USD in revenues.
On its last earning announcement, the company reported a profit of 0.69$ per share.
The book value per share is 1.15$
Three months stock forecastJan. 6, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|